查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790357

美国乳房保留手术市场规模、份额及趋势分析报告：按手术类型、产品、最终用途和细分市场进行预测（2025-2033 年）

U.S. Breast Conserving Surgery Market Size, Share & Trends Analysis Report By Procedure (Lumpectomy, Quadrantectomy, Segmental Mastectomy), By Product, By End Use (Hospitals, Ambulatory Surgery Centers), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

市场规模和趋势

预计 2024 年美国乳房保留手术市场价值将达到 7.4432 亿美元，预计 2025 年至 2033 年的复合年增长率为 7.18%。

市场成长的动力源自于早期乳癌盛行率的不断上升，这得益于乳房X光摄影检查筛检计画和病患意识提升宣传活动的广泛发展。这些措施提高了早期发现率，使更多患者有资格接受乳房肿瘤切除术和切除术等乳房保留手术。此外，尤其是年轻患者，强烈渴望接受能够保留乳房外观和功能的手术，这符合乳房保留手术 (BCS) 的原则。

门诊手术设施的成长是美国市场的主要驱动力，它们为住院手术提供了经济高效且对患者友好的替代方案。这些设施越来越多地配备了先进的手术技术、经验丰富的医护人员和精简的流程，通常非常适合像BCS这样创伤性较小、恢復时间较短的手术。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国乳房保留手术市场变数、趋势与范围

  • 市场体系展望
    • 相关/辅助市场展望
  • 使用者观点分析
    • 消费行为分析
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国乳房保留手术市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

第四章美国保乳手术市场：依手术类型、估价及趋势分析

  • 细分仪表板
  • 美国乳房保留手术市场：2024 年及 2033 年手术变异分析及市场占有率
  • 切除术
  • 切除术
  • 部分乳房切除术

第五章：美国保乳手术市场：产品、估值与趋势分析

  • 细分仪表板
  • 美国乳房保留手术市场：2024 年和 2033 年产品变化分析和市场占有率
  • 肿瘤定位装置
    • 有线引导定位
    • 磁性种子定位
    • 基于雷达的定位
    • 其他的
  • 手术切除装置
    • 电外科手术单元/设备
    • 手术刀/镊子/牵开器/夹子
    • 真空切片检查系统
    • 其他的
  • 裕度评估装置
  • 术中成像和导航设备

第六章美国保乳手术市场：以最终用途的估计和趋势分析

  • 细分仪表板
  • 美国乳房保留手术市场：2024 年和 2033 年最终用途变化分析和市场占有率
  • 医院
  • 门诊手术中心
  • 肿瘤科/专科诊所
  • 其他的

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • 2024年主要企业市场占有率分析
    • Hologic, Inc
    • Argon Medical Devices
    • Merit Medical Systems
    • KUBTEC
    • Stryker
    • Mammotome（Danaher）
    • CairnSurgical Inc.
    • Lumicell Inc
    • Innoblative Designs
    • Perimeter Medical Imaging AI
Product Code: GVR-4-68040-660-3

Market Size & Trends:

The U.S. breast conserving surgery market size was estimated at USD 744.32 million in 2024 and is projected to grow at a CAGR of 7.18% from 2025 to 2033. The market growth is attributed to the rising prevalence of early-stage breast cancer, supported by widespread mammography screening programs and patient awareness campaigns. These initiatives have led to an increase in early detection rates, making more patients eligible for breast-conserving procedures like lumpectomy and quadrantectomy. In addition, there is a strong preference for procedures that preserve breast appearance and function, especially among younger patients, which aligns with the principles of breast conserving surgery (BCS).

The growth of ambulatory surgical settings is a key driver of the U.S. market, offering a cost-effective, patient-friendly alternative to inpatient hospital procedures. These settings are increasingly equipped with advanced surgical technologies, experienced staff, and streamlined processes that make them well suited for procedures like BCS, which are typically less invasive and have shorter recovery times.

U.S. Breast Conserving Surgery Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. breast conserving surgery market report based on procedure, product, and end use:

  • Procedure Outlook (Revenue, USD Million, 2021 - 2033)
  • Lumpectomy
  • Quadrantectomy
  • Segmental Mastectomy
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Tumor Localization Devices
    • Wire-guided localization
    • Magnetic seed localization
    • Radar-based localization
    • Others
  • Surgical Excision Devices
    • Electrosurgical units/devices
    • Scalpels/forceps/retractors/clamps
    • Vacuum-assisted biopsy systems
    • Others
  • Margin Assessment Devices
  • Intraoperative Imaging & Navigation Devices
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgery Centers
  • Oncology/Specialty Clinics
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Third Party Perspective
    • 1.3.5. Primary research
    • 1.3.6. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights Outlook

Chapter 3. U.S. Breast Conserving Surgery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Related/ancillary market outlook.
  • 3.2. User Perspective Analysis
    • 3.2.1. Consumer behavior analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing breast cancer incidence and focus on early detection
      • 3.3.1.2. Rising preference for cosmetic and functional preservation
      • 3.3.1.3. Technological advancement in wireless localization and AI-based margin assessment
      • 3.3.1.4. Growth of ambulatory surgical settings
      • 3.3.1.5. Favorable government and reimbursement support in developed nations
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. High cost of advanced technologies
      • 3.3.2.2. Limited access to early diagnosis
    • 3.3.3. Market opportunity analysis
      • 3.3.3.1. Shift toward outpatient & minimally invasive procedures
    • 3.3.4. Market challenge analysis
      • 3.3.4.1. Reoperation risk due to positive margins
  • 3.4. U.S. Breast Conserving Surgery Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. U.S. Breast Conserving Surgery Market: Procedure Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Breast Conserving Surgery Market: Procedure Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Lumpectomy
    • 4.3.1. Lumpectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Quadrantectomy
    • 4.4.1. Quadrantectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Segmental Mastectomy
    • 4.5.1. Segmental Mastectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast Conserving Surgery Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Breast Conserving Surgery Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Tumor Localization Devices
    • 5.3.1. Tumor Localization Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Wire-Guided Localization
      • 5.3.2.1. Wire-guided localization market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.3. Magnetic Seed Localization
      • 5.3.3.1. Magnetic seed localization market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.4. Radar-Based Localization
      • 5.3.4.1. Radar-based localization market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.5. Others
      • 5.3.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4. Surgical Excision Devices
    • 5.4.1. Surgical Excision Devices Market Estimates And Forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Electrosurgical Units/Devices
      • 5.4.2.1. Electrosurgical units/devices market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Scalpels/Forceps/Retractors/Clamps
      • 5.4.3.1. Scalpels/forceps/retractors/clamps market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.4. Vacuum-Assisted Biopsy Systems
      • 5.4.4.1. Vacuum-assisted biopsy systems market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.5. Other
      • 5.4.5.1. Other market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Margin Assessment Devices
    • 5.5.1. Margin Assessment Devices Market Estimates And Forecasts 2021 to 2033 (USD Million)
  • 5.6. Intraoperative Imaging & Navigation Devices
    • 5.6.1. Intraoperative Imaging & Navigation Devices Market Estimates And Forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Breast Conserving Surgery Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Breast Conserving Surgery Market: End Use Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Ambulatory Surgery Centers
    • 6.4.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Oncology/Specialty Clinics
    • 6.5.1. Oncology/Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2024
    • 7.3.4. Hologic, Inc
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Argon Medical Devices
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Merit Medical Systems
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. KUBTEC
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Stryker
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Mammotome (Danaher)
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. CairnSurgical Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Lumicell Inc
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Innoblative Designs
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Perimeter Medical Imaging AI
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. breast conserving surgery market, by procedure, 2021 - 2033 (USD Million)
  • Table 4 U.S. breast conserving surgery market, by product, 2021 - 2033 (USD Million)
  • Table 5 U.S. breast conserving surgery market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Breast conserving surgery market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Segment outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Consumer behavior analysis
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's Five Forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 Lumpectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Quadrantectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Segmental mastectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Tumor localization devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Wire-guided localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Magnetic seed localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Radar-based localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Surgical excision devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Electrosurgical units/devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Scalpels/forceps/retractors/clamps market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Vacuum-assisted biopsy systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Margin assessment devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Intraoperative imaging & navigation devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Ambulatory surgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Oncology/specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Company market share analysis, 2024
  • Fig. 38 Market differentiators